Literature DB >> 9777283

The differential effect of personality on computer-based treatment of agoraphobia.

L Harcourt1, K Kirkby, B Daniels, I Montgomery.   

Abstract

The differential effects of the revised NEO Personality Inventory (NEO PI-R) personality factors and intelligence on response to a computerized vicarious exposure treatment for agoraphobia were investigated. The Fear Questionnaire (FQ), the Agoraphobia Cognitions Questionnaire (ACQ), and the Body Sensations Questionnaire (BSQ) were used to assess agoraphobic symptomatology. Fourteen females and four males with agoraphobia diagnoses completed three 45-minute weekly treatment sessions. There was a significant decrease in scores on all three measures following treatment. Compared with published population norms, the agoraphobic subjects showed very high neuroticism, low extroversion, and high openness. Lower agreeableness factor scores predicted good treatment outcome. The NEO PI-R openness factor was negatively correlated with proficiency on the computer program; however, proficiency on the computer program did not correlate with symptom improvement. Overall, these results suggest that personality interacts with treatment at different stages of the therapeutic process.

Entities:  

Mesh:

Year:  1998        PMID: 9777283     DOI: 10.1016/s0010-440x(98)90039-6

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  2 in total

1.  D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.

Authors:  Jasper A J Smits; Stefan G Hofmann; David Rosenfield; Lindsey B DeBoer; Paul T Costa; Naomi M Simon; Conall O'Cleirigh; Alicia E Meuret; Luana Marques; Michael W Otto; Mark H Pollack
Journal:  J Consult Clin Psychol       Date:  2013-08-12

2.  The Effect of Personality Traits on Cognitive Behavioral Therapy Outcomes in Student Pharmacists with Rat Phobia: A Randomized Clinical Trial.

Authors:  Camellia Hemyari; Kamiar Zomorodian; Maryam Shojaee; Ali Sahraian; Behrooz Dolatshahi
Journal:  Iran J Med Sci       Date:  2021-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.